STOCK TITAN

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Alexander Hardy, the company's President and Chief Executive Officer, will deliver a presentation on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET.

The presentation will be accessible through a live audio webcast on the company's investor relations website. For those unable to attend or watch live, an archived version of the presentation will be available for a time through BioMarin's website.

BioMarin Pharmaceutical (NASDAQ: BMRN) ha annunciato la sua partecipazione alla 43esima Conferenza Annuale J.P. Morgan Healthcare a San Francisco, California. Alexander Hardy, il Presidente e Amministratore Delegato dell'azienda, presenterà un intervento lunedì 13 gennaio 2024, alle 9:00 PST / 12:00 EST.

La presentazione sarà accessibile tramite un webcast audio in diretta sul sito web delle relazioni con gli investitori dell'azienda. Per coloro che non potranno partecipare o assistere in diretta, sarà disponibile una versione archiviata della presentazione per un certo periodo sul sito web di BioMarin.

BioMarin Pharmaceutical (NASDAQ: BMRN) ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan en San Francisco, California. Alexander Hardy, el presidente y director ejecutivo de la compañía, dará una presentación el lunes 13 de enero de 2024, a las 9:00 a.m. PT / 12:00 p.m. ET.

La presentación será accesible a través de una transmisión de audio en vivo en el sitio web de relaciones con inversores de la compañía. Para aquellos que no puedan asistir o ver en vivo, estará disponible una versión archivada de la presentación por un tiempo en el sitio web de BioMarin.

BioMarin Pharmaceutical (NASDAQ: BMRN)가 샌프란시스코, 캘리포니아에서 열리는 제43회 JP모건 헬스케어 콘퍼런스에 참석한다고 발표했습니다. 알렉산더 하디 회사의 회장 겸 CEO가 2024년 1월 13일 월요일 오전 9시 PT / 오후 12시 ET에 발표를 할 것입니다.

발표는 회사의 투자자 관계 웹사이트를 통해 실시간 오디오 웹캐스트로 접근할 수 있습니다. 참석하지 못하거나 실시간으로 볼 수 없는 분들을 위해 BioMarin 웹사이트에서 일정 기간 아카이브된 발표 버전이 제공될 것입니다.

BioMarin Pharmaceutical (NASDAQ: BMRN) a annoncé sa participation à la 43ème Conférence Annuelle de J.P. Morgan Healthcare à San Francisco, Californie. Alexander Hardy, le président-directeur général de l'entreprise, fera une présentation le lundi 13 janvier 2024, à 9h00 PT / 12h00 ET.

La présentation sera accessible via un webinaire audio en direct sur le site Internet des relations investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister ou visionner en direct, une version archivée de la présentation sera disponible pendant un certain temps sur le site de BioMarin.

BioMarin Pharmaceutical (NASDAQ: BMRN) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco, Kalifornien, bekannt gegeben. Alexander Hardy, der Präsident und CEO des Unternehmens, wird am Montag, den 13. Januar 2024, um 9:00 Uhr PT / 12:00 Uhr ET eine Präsentation halten.

Die Präsentation wird über einen Live-Audio-Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein. Für diejenigen, die nicht live teilnehmen oder zuschauen können, wird eine archivierte Version der Präsentation für einen gewissen Zeitraum auf der Website von BioMarin verfügbar sein.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Jan. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 43rd Annual J.P. Morgan Conference on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET, in San Francisco, California.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.   

Contacts:


Investors

Media

Traci McCarty

Marni Kottle

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(650) 374-2803

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-on-monday-january-13-at-900-am-pt--1200-pm-et-in-san-francisco-ca-302342007.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin (BMRN) presenting at the 2024 J.P. Morgan Healthcare Conference?

BioMarin (BMRN) is presenting on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET in San Francisco, California.

How can investors watch BioMarin's (BMRN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live audio webcast available at BioMarin's investor relations website: https://investors.biomarin.com/

Who will be presenting for BioMarin (BMRN) at the 2024 J.P. Morgan Healthcare Conference?

Alexander Hardy, BioMarin's President and Chief Executive Officer, will be presenting at the conference.

Will BioMarin's (BMRN) J.P. Morgan Healthcare Conference presentation be available after the event?

Yes, an archived version of the presentation will be available through BioMarin's website for a time following the conference.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.93B
188.90M
0.87%
97.36%
2.73%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO